Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells

Leukemia. 2020 Jun;34(6):1679-1683. doi: 10.1038/s41375-020-0708-1. Epub 2020 Jan 24.

Hein Than^#^{1

2}, Anthony D Pomicter^#¹, Dongqing Yan¹, Larry P Beaver¹, Anna M Eiring¹, William L Heaton¹, Anna Senina¹, Phillip M Clair¹, Sharon Shacham³, Clinton C Mason⁴, Thomas O' Hare^{1

5}, Michael W Deininger^{6

7}

¹ Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
² Department of Hematology, Singapore General Hospital, Singapore, Singapore.
³ Karyopharm Therapeutics, Inc, Newton, MA, USA.
⁴ Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, UT, USA.
⁵ Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.
⁶ Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. [email protected].
⁷ Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA. [email protected].

^# Contributed equally.

No abstract available

Publication types